Abiopharma

New Form 4 - COGNITION THERAPEUTICS INC Filed: 2025-07-31 AccNo: 0001062993-25-013356 Size: 7 KB

New Form 8-K - NEXGEL, INC. Filed: 2025-07-31 AccNo: 0001641172-25-021743 Size: 17 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - EASTMAN CHEMICAL CO Filed: 2025-07-31 AccNo: 0000915389-25-000152 Size: 875 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Envista Holdings Corp Filed: 2025-07-31 AccNo: 0001757073-25-000044 Size: 8 MB

New Form 424B3 - Gryphon Digital Mining, Inc. Filed: 2025-07-31 AccNo: 0001213900-25-069998 Size: 24 MB

New Form 8-K - Alphatec Holdings, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100924 Size: 985 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - SOLIGENIX, INC. Filed: 2025-07-31 AccNo: 0001104659-25-072708 Size: 307 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 10-Q - BIO-RAD LABORATORIES, INC. Filed: 2025-07-31 AccNo: 0000012208-25-000052 Size: 9 MB

New Form 10-Q - BALCHEM CORP Filed: 2025-07-31 AccNo: 0000009326-25-000014 Size: 8 MB

Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025

SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical

New Form 8-K - BIO-RAD LABORATORIES, INC. Filed: 2025-07-31 AccNo: 0000012208-25-000051 Size: 2 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 10-Q - FibroBiologics, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100917 Size: 8 MB

New Form 8-K - Ultragenyx Pharmaceutical Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100918 Size: 154 KB Item 8.01: Other Events